223 related articles for article (PubMed ID: 16939701)
1. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor.
Deng H; Le W; Davidson AL; Xie W; Jankovic J
Neurosci Lett; 2006 Oct; 407(2):97-100. PubMed ID: 16939701
[TBL] [Abstract][Full Text] [Related]
2. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
3. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.
Lu CS; Simons EJ; Wu-Chou YH; Fonzo AD; Chang HC; Chen RS; Weng YH; Rohé CF; Breedveld GJ; Hattori N; Gasser T; Oostra BA; Bonifati V
Parkinsonism Relat Disord; 2005 Dec; 11(8):521-2. PubMed ID: 16256409
[No Abstract] [Full Text] [Related]
4. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
Pankratz N; Pauciulo MW; Elsaesser VE; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Nichols WC;
Mov Disord; 2006 Dec; 21(12):2257-60. PubMed ID: 17078063
[TBL] [Abstract][Full Text] [Related]
5. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
6. Clinical heterogeneity of the LRRK2 G2019S mutation.
Papapetropoulos S; Singer C; Ross OA; Toft M; Johnson JL; Farrer MJ; Mash DC
Arch Neurol; 2006 Sep; 63(9):1242-6. PubMed ID: 16966501
[TBL] [Abstract][Full Text] [Related]
7. Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients.
Punia S; Behari M; Govindappa ST; Swaminath PV; Jayaram S; Goyal V; Muthane UB; Juyal RC; Thelma BK
Neurosci Lett; 2006 Dec; 409(2):83-8. PubMed ID: 17052850
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.
Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG
Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725
[TBL] [Abstract][Full Text] [Related]
9. Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.
Pchelina SN; Yakimovskii AF; Emelyanov AK; Ivanova ON; Schwarzman AL; Singleton AB
Eur J Neurol; 2008 Jul; 15(7):692-6. PubMed ID: 18435766
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
[TBL] [Abstract][Full Text] [Related]
11. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.
Tomiyama H; Li Y; Funayama M; Hasegawa K; Yoshino H; Kubo S; Sato K; Hattori T; Lu CS; Inzelberg R; Djaldetti R; Melamed E; Amouri R; Gouider-Khouja N; Hentati F; Hatano Y; Wang M; Imamichi Y; Mizoguchi K; Miyajima H; Obata F; Toda T; Farrer MJ; Mizuno Y; Hattori N
Mov Disord; 2006 Aug; 21(8):1102-8. PubMed ID: 16622854
[TBL] [Abstract][Full Text] [Related]
12. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
[TBL] [Abstract][Full Text] [Related]
13. LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: clinical, PET, and functional studies.
Lin CH; Tzen KY; Yu CY; Tai CH; Farrer MJ; Wu RM
J Biomed Sci; 2008 Sep; 15(5):661-7. PubMed ID: 18523869
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor.
Clark LN; Kisselev S; Park N; Ross B; Verbitsky M; Rios E; Alcalay RN; Lee JH; Louis ED
Parkinsonism Relat Disord; 2010 Feb; 16(2):132-5. PubMed ID: 19527940
[TBL] [Abstract][Full Text] [Related]
15. Absence of commonly reported leucine-rich repeat kinase 2 mutations in Eastern Indian Parkinson's disease patients.
Sanyal J; Sarkar B; Ojha S; Banerjee TK; Ray BC; Rao VR
Genet Test Mol Biomarkers; 2010 Oct; 14(5):691-4. PubMed ID: 20722494
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.
Infante J; Rodríguez E; Combarros O; Mateo I; Fontalba A; Pascual J; Oterino A; Polo JM; Leno C; Berciano J
Neurosci Lett; 2006 Mar; 395(3):224-6. PubMed ID: 16298482
[TBL] [Abstract][Full Text] [Related]
17. Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania.
De Rosa A; De Michele G; Guacci A; Carbone R; Lieto M; Peluso S; Picillo M; Barone P; Salemi F; Laiso A; Saccà F; Tessitore A; Pellecchia MT; Bonifati V; Criscuolo C
J Parkinsons Dis; 2014; 4(1):123-8. PubMed ID: 24496098
[TBL] [Abstract][Full Text] [Related]
18. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
[TBL] [Abstract][Full Text] [Related]
19. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.
Carmine Belin A; Westerlund M; Sydow O; Lundströmer K; Håkansson A; Nissbrandt H; Olson L; Galter D
Mov Disord; 2006 Oct; 21(10):1731-4. PubMed ID: 16817197
[TBL] [Abstract][Full Text] [Related]
20. Lrrk2 R1628P variant is a risk factor for essential tremor.
Chao YX; Ng EY; Tan L; Prakash KM; Au WL; Zhao Y; Tan EK
Sci Rep; 2015 Mar; 5():9029. PubMed ID: 25761573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
